Publication | Closed Access
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer
77
Citations
29
References
2009
Year
Due to their specific binding characteristics, the anti-PSMA mAbs 3/A12, 3/E7, and 3/F11 show great promise for diagnostic and therapeutic applications in prostate cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1